These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Impaired long-term potentiation in vivo in the dentate gyrus of pituitary adenylate cyclase-activating polypeptide (PACAP) or PACAP type 1 receptor-mutant mice. Matsuyama S; Matsumoto A; Hashimoto H; Shintani N; Baba A Neuroreport; 2003 Nov; 14(16):2095-8. PubMed ID: 14600504 [TBL] [Abstract][Full Text] [Related]
45. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes. Grimaldi M; Cavallaro S Eur J Neurosci; 1999 Aug; 11(8):2767-72. PubMed ID: 10457173 [TBL] [Abstract][Full Text] [Related]
46. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433 [TBL] [Abstract][Full Text] [Related]
47. Pituitary adenylate cyclase-activating polypeptide regulates rat Leydig cell function in vitro. Romanelli F; Fillo S; Isidori A; Conte D Neuropeptides; 1997 Aug; 31(4):311-7. PubMed ID: 9308016 [TBL] [Abstract][Full Text] [Related]
48. Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells. Zhang W; Duan W; Cheung NS; Huang Z; Shao K; Li QT J Neurochem; 2007 Nov; 103(3):1157-67. PubMed ID: 17680996 [TBL] [Abstract][Full Text] [Related]
49. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. Mounien L; Do Rego JC; Bizet P; Boutelet I; Gourcerol G; Fournier A; Brabet P; Costentin J; Vaudry H; Jégou S Neuropsychopharmacology; 2009 Jan; 34(2):424-35. PubMed ID: 18536705 [TBL] [Abstract][Full Text] [Related]
50. PACAP enhances axon outgrowth in cultured hippocampal neurons to a comparable extent as BDNF. Ogata K; Shintani N; Hayata-Takano A; Kamo T; Higashi S; Seiriki K; Momosaki H; Vaudry D; Vaudry H; Galas L; Kasai A; Nagayasu K; Nakazawa T; Hashimoto R; Ago Y; Matsuda T; Baba A; Hashimoto H PLoS One; 2015; 10(3):e0120526. PubMed ID: 25807538 [TBL] [Abstract][Full Text] [Related]
51. Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Pathway Is Induced by Mechanical Load and Reduces the Activity of Hedgehog Signaling in Chondrogenic Micromass Cell Cultures. Juhász T; Szentléleky E; Somogyi CS; Takács R; Dobrosi N; Engler M; Tamás A; Reglődi D; Zákány R Int J Mol Sci; 2015 Jul; 16(8):17344-67. PubMed ID: 26230691 [TBL] [Abstract][Full Text] [Related]
52. Neural tube expression of pituitary adenylate cyclase-activating peptide (PACAP) and receptor: potential role in patterning and neurogenesis. Waschek JA; Casillas RA; Nguyen TB; DiCicco-Bloom EM; Carpenter EM; Rodriguez WI Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9602-7. PubMed ID: 9689127 [TBL] [Abstract][Full Text] [Related]
53. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. Villalba M; Bockaert J; Journot L J Neurosci; 1997 Jan; 17(1):83-90. PubMed ID: 8987738 [TBL] [Abstract][Full Text] [Related]
54. Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors. Juarranz MG; Bolaños O; Gutiérrez-Cañas I; Lerner EA; Robberecht P; Carmena MJ; Prieto JC; Rodríguez-Henche N Cell Signal; 2001 Dec; 13(12):887-94. PubMed ID: 11728828 [TBL] [Abstract][Full Text] [Related]
55. Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain. D'Agata V; Cavallaro S; Stivala F; Canonico PL Eur J Neurosci; 1996 Feb; 8(2):310-8. PubMed ID: 8714702 [TBL] [Abstract][Full Text] [Related]
56. Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice. Markovics A; Kormos V; Gaszner B; Lashgarara A; Szoke E; Sandor K; Szabadfi K; Tuka B; Tajti J; Szolcsanyi J; Pinter E; Hashimoto H; Kun J; Reglodi D; Helyes Z Neurobiol Dis; 2012 Jan; 45(1):633-44. PubMed ID: 22033344 [TBL] [Abstract][Full Text] [Related]
57. PAC1- and VPAC2 receptors in light regulated behavior and physiology: Studies in single and double mutant mice. Hannibal J; Georg B; Fahrenkrug J PLoS One; 2017; 12(11):e0188166. PubMed ID: 29155851 [TBL] [Abstract][Full Text] [Related]
58. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex. Zawilska JB; Niewiadomski P; Nowak JZ Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071 [TBL] [Abstract][Full Text] [Related]
59. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding. Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375 [TBL] [Abstract][Full Text] [Related]
60. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development. Basille M; Vaudry D; Coulouarn Y; Jegou S; Lihrmann I; Fournier A; Vaudry H; Gonzalez B J Comp Neurol; 2000 Oct; 425(4):495-509. PubMed ID: 10975876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]